OPTICal Illusions: Apixaban for Prevention of VTE and Omadacycline for Community-Acquired Bacterial Pneumonia
Healthy Debate
MARCH 8, 2019
Together they cover apixaban therapy to prevent venous thromboembolism (VTE) in patients with cancer, and omadacycline for treatment of community-acquired bacterial pneumonia (the OPTIC trial). Interested in helping us evaluate our podcast episodes? OPTIC trial: [link] Good Stuff 1. If you’re interested, email wkwong@qmed.ca.
Let's personalize your content